Pamlectabart
Product Specifications
Target
TNF
Related Pathways
Apoptosis
Purity
0.966
Bioactivity
Pamlectabart is a humanised antibody targeting TNFRSF17/BCMA, which can be used to synthesise the antibody-drug conjugate (ADC) Pamlectabart tismanitin for the study of multiple myeloma.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL502941V 500 µL Each
Txnl1 Mouse shRNA Lentiviral Particle (Locus ID 53382)
Sign In for Pricing
View Details IRBARTPAI1GFFITC10MG 10 mg
*Rabbit Anti Rat PAI-1 Polyclonal Fractionated FITC Labeled
Sign In for Pricing
View Details 226452-01 50 µL
TRIM13 (B Cell chronic lymphocytic Leukemia Tumor Suppressor Leu5, B-Cell chronic lymphocytic Leukemia Tumor Suppressor Leu5, CAR, DLEU5, E3 Ubiquitin-Protein Ligase TRIM13, HGNC:9976, LEU5, Leukemia Associated Protein 5, Leukemia-Associated Protein 5, Putative Tumor Suppressor RFP2, Ret Finger Protein 2, RING Finger Protein 77, RNF77, TRI13_HUMAN, TRIM13, Tripartite Motif Protein 13, Tripartite Motif-Containing Protein 13, ) discontinued
Sign In for Pricing
View Details 226452-02 100 µL
TRIM13 (B Cell chronic lymphocytic Leukemia Tumor Suppressor Leu5, B-Cell chronic lymphocytic Leukemia Tumor Suppressor Leu5, CAR, DLEU5, E3 Ubiquitin-Protein Ligase TRIM13, HGNC:9976, LEU5, Leukemia Associated Protein 5, Leukemia-Associated Protein 5, Putative Tumor Suppressor RFP2, Ret Finger Protein 2, RING Finger Protein 77, RNF77, TRI13_HUMAN, TRIM13, Tripartite Motif Protein 13, Tripartite Motif-Containing Protein 13, ) discontinued
Sign In for Pricing
View Details